312 related articles for article (PubMed ID: 23359570)
1. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.
Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H
Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570
[TBL] [Abstract][Full Text] [Related]
2. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
[TBL] [Abstract][Full Text] [Related]
3. A truncating mutation in B3GNT1 causes severe Walker-Warburg syndrome.
Shaheen R; Faqeih E; Ansari S; Alkuraya FS
Neurogenetics; 2013 Nov; 14(3-4):243-5. PubMed ID: 23877401
[TBL] [Abstract][Full Text] [Related]
4. 160 kb deletion in ISPD unmasking a recessive mutation in a patient with Walker-Warburg syndrome.
Czeschik JC; Hehr U; Hartmann B; Lüdecke HJ; Rosenbaum T; Schweiger B; Wieczorek D
Eur J Med Genet; 2013 Dec; 56(12):689-94. PubMed ID: 24120487
[TBL] [Abstract][Full Text] [Related]
5. Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration.
Tachikawa M; Kanagawa M; Yu CC; Kobayashi K; Toda T
J Biol Chem; 2012 Mar; 287(11):8398-406. PubMed ID: 22275357
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish models for human FKRP muscular dystrophies.
Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
[TBL] [Abstract][Full Text] [Related]
7. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan.
Roscioli T; Kamsteeg EJ; Buysse K; Maystadt I; van Reeuwijk J; van den Elzen C; van Beusekom E; Riemersma M; Pfundt R; Vissers LE; Schraders M; Altunoglu U; Buckley MF; Brunner HG; Grisart B; Zhou H; Veltman JA; Gilissen C; Mancini GM; Delrée P; Willemsen MA; Ramadža DP; Chitayat D; Bennett C; Sheridan E; Peeters EA; Tan-Sindhunata GM; de Die-Smulders CE; Devriendt K; Kayserili H; El-Hashash OA; Stemple DL; Lefeber DJ; Lin YY; van Bokhoven H
Nat Genet; 2012 May; 44(5):581-5. PubMed ID: 22522421
[TBL] [Abstract][Full Text] [Related]
8. [Recent Advances in α-dystroglycanopathy].
Kuga A; Kanagawa M; Toda T
Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
[TBL] [Abstract][Full Text] [Related]
9. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
[TBL] [Abstract][Full Text] [Related]
10. Clinical long-time course, novel mutations and genotype-phenotype correlation in a cohort of 27 families with POMT1-related disorders.
Geis T; Rödl T; Topaloğlu H; Balci-Hayta B; Hinreiner S; Müller-Felber W; Schoser B; Mehraein Y; Hübner A; Zirn B; Hoopmann M; Reutter H; Mowat D; Schuierer G; Schara U; Hehr U; Kölbel H
Orphanet J Rare Dis; 2019 Jul; 14(1):179. PubMed ID: 31311558
[TBL] [Abstract][Full Text] [Related]
11. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.
Willer T; Lee H; Lommel M; Yoshida-Moriguchi T; de Bernabe DB; Venzke D; Cirak S; Schachter H; Vajsar J; Voit T; Muntoni F; Loder AS; Dobyns WB; Winder TL; Strahl S; Mathews KD; Nelson SF; Moore SA; Campbell KP
Nat Genet; 2012 May; 44(5):575-80. PubMed ID: 22522420
[TBL] [Abstract][Full Text] [Related]
12. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
[TBL] [Abstract][Full Text] [Related]
13. Glyc-O-genetics of Walker-Warburg syndrome.
van Reeuwijk J; Brunner HG; van Bokhoven H
Clin Genet; 2005 Apr; 67(4):281-9. PubMed ID: 15733261
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
Beltrán-Valero de Bernabé D; Currier S; Steinbrecher A; Celli J; van Beusekom E; van der Zwaag B; Kayserili H; Merlini L; Chitayat D; Dobyns WB; Cormand B; Lehesjoki AE; Cruces J; Voit T; Walsh CA; van Bokhoven H; Brunner HG
Am J Hum Genet; 2002 Nov; 71(5):1033-43. PubMed ID: 12369018
[TBL] [Abstract][Full Text] [Related]
15. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
17. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
Balci-Hayta B; Talim B; Kale G; Dincer P
BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in congenital muscular dystrophy research].
Nonaka I
No To Hattatsu; 2005 Mar; 37(2):115-21. PubMed ID: 15773323
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
[TBL] [Abstract][Full Text] [Related]
20. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
